BGI A Kit for Quantitative Determination of C-Peptide (C-P)

BGI A Kit for Quantitative Determination of C-Peptide (C-P)

Product overview

The BGI A Kit for Quantitative Determination of C-Peptide (C-P) is a BGI reagent kit listed within the Chemiluminescence Reagents portfolio. Chemiluminescence immunoassay (CLIA) is a combination of highly sensitive chemiluminescence assay technology and highly specific immune response, which can be used for detection and analysis of various antigens, antibodies, hormones, enzymes, drugs and so on. It is a new immunoassay technology developed after radioimmunoassay, enzyme immunoassay and fluorescence immunoassay. It is widely used in clinical and physical examination because of its high sensitivity, specificity, stability and rapidity, wide detection range, simple operation and high automation.

Key features

• BGI-branded reagent kit for professional laboratory use
• Part of the Diabetes Detection Series product series
• Associated platform: Chemiluminescence immunoassay (CLIA)
• Available configuration and regulatory status may vary by market

Applications

Intended for professional laboratory testing related to A Kit for Quantitative Determination of C-Peptide (C-P). The exact specimen type, clinical indication and interpretation requirements depend on the registered configuration and local authorization.

Technical specifications

Ordering and configuration

Contact Scientific China for the current BGI catalog number, intended-use version, compatible platform, pack size, minimum order quantity, lead time, shipping conditions, certificates and formal quotation.